We are seeking approximately 120 participants to take part in an upcoming 28-day research study evaluating a Qualia perimenopause formulation designed to support women during the perimenopausal transition.
Participants will be randomly assigned and will be asked to take 1 capsule once daily in the morning with food for 28 consecutive days.
This study will be conducted in women aged 40–55 and will focus on subjective experience and self-reported outcomes during the study period.
This is not the final study application. If you are interested in participating, please complete the two short surveys below to join the waitlist. We will be following up with the full study application within the next two weeks.
Upon completion of all study requirements, participants may earn up to $150 in Qualia Life Sciences store credit as a thank-you for their time and participation.
*US only
*This study is being conducted by Qualia Life Science
Pre-screening surveys are used solely to determine eligibility for participation.
Data will be securely stored on Qualia Life Sciences servers, accessible only to authorized personnel.
A final follow-up survey will be sent to collect additional feedback and reviews that may be featured in our marketing materials.